Dibasic Sodium Phosphate, Monobasic Potassium Phosphate And Monobasic Sodium Phosphate

Prescription

Tên thương mại: Dibasic Sodium Phosphate, Monobasic Potassium Phosphate and Monobasic Sodium Phosphate

Dạng bào chế

Tablet

Đường dùng

ORAL

Nhà sản xuất

Rising Pharma Holdings, Inc.

About This Medication

DESCRIPTION Each tablet contains 852 mg dibasic sodium phosphate anhydrous, 155 mg monobasic potassium phosphate, and 130 mg monobasic sodium phosphate monohydrate. Each tablet yields approximately 250 mg of phosphorus, 298 mg of sodium (13.0 mEq) and 45 mg of potassium (1 .1 mEq).

Hoạt chất

Thành phần	Hàm lượng
Potassium Phosphate, Monobasic	-
Sodium Phosphate, Dibasic, Anhydrous	-
Sodium Phosphate, Monobasic, Monohydrate	-

Chỉ định & Cách dùng

INDICATIONS AND USAGE PHOSPHA 250 TM NEUTRAL increases urinary phosphate and pyrophosphate. As a phosphorus supplement, each tablet supplies 25% of the U.S. Recommended Daily Allowance (U.S. RDA) of phosphorus for adults and children over 4 years of age.

Liều dùng & Cách dùng

DOSAGE AND ADMINISTRATION PHOSPHA 250 TM NEUTRAL tablets should be taken with a full glass of water, with meals and at bedtime. Adults: One or two tablets, four times daily; Pediatric patients over 4 years of age: One tablet four times daily. Pediatric Patients under 4 years of age: Use only as directed by physician.

Side Effects Overview

ADVERSE REACTIONS: Gastrointestinal upset (diarrhea, nausea, stomach pain, and vomiting) may occur with phosphate therapy. Also, bone and joint pain (possible phosphate-induced osteomalacia) could occur. The following adverse effects may be observed (primarily from sodium or potassium): headaches; dizziness; mental confusion; seizures; weakness or heaviness of legs; unusual tiredness or weakness; muscle cramps; numbness, tingling, pain or weakness of hands or feet; numbness or tingling around lips; fast or irregular heartbeat; shortness of breath or troubled breathing; swelling of feet or lower legs; unusual weight gain; low urine output; unusual thirst. To report SUSPECTED ADVERSE REACTIONS, contact Rising Pharma Holdings, Inc., at 1-844-874-7464 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

Chống chỉ định

CONTRAINDICATIONS This product is contraindicated in patients with infected phosphate stones, in patients with severely impaired renal function (less than 30% of normal) and in the presence of hyperphosphatemia.

Frequently Asked Questions

INDICATIONS AND USAGE PHOSPHA 250 TM NEUTRAL increases urinary phosphate and pyrophosphate. As a phosphorus supplement, each tablet supplies 25% of the U.S. Recommended Daily Allowance (U.S. RDA) of phosphorus for adults and children over 4 years of age.

DOSAGE AND ADMINISTRATION PHOSPHA 250 TM NEUTRAL tablets should be taken with a full glass of water, with meals and at bedtime. Adults: One or two tablets, four times daily; Pediatric patients over 4 years of age: One tablet four times daily. Pediatric Patients under 4 years of age: Use only as directed by physician.

CONTRAINDICATIONS This product is contraindicated in patients with infected phosphate stones, in patients with severely impaired renal function (less than 30% of normal) and in the presence of hyperphosphatemia.

Dibasic Sodium Phosphate, Monobasic Potassium Phosphate And Monobasic Sodium Phosphate is a prescription medication. You will need a valid prescription from a licensed healthcare provider.

Similar Tablet Products

Fostamatinib

Aralia Racemosa Root

Acetaminophen, Diphenhydramine Hydrochloride

Spigelia Anthelmia, Phytolacca Decandra, …

Thyroid, Unspecified

Ruta Grav

Browse all Tablet products →

References & Data Sources

• DailyMed — Dibasic Sodium Phosphate, Monobasic Potassium Phosphate And Monobasic Sodium Phosphate drug label (National Library of Medicine)
• openFDA — Dibasic Sodium Phosphate, Monobasic Potassium Phosphate And Monobasic Sodium Phosphate label data (U.S. Food & Drug Administration)
• RxNorm — RXCUI 200251 (NLM Normalized Drug Names)
• NDC Directory — Dibasic Sodium Phosphate, Monobasic Potassium Phosphate And Monobasic Sodium Phosphate (FDA National Drug Code)

Tuyên bố miễn trách nhiệm y tế

Thông tin trên trang này chỉ nhằm mục đích giáo dục và không nên được sử dụng thay thế cho lời khuyên y tế chuyên nghiệp, chẩn đoán hoặc điều trị.

Luôn tìm kiếm lời khuyên của bác sĩ hoặc nhà cung cấp dịch vụ y tế có chuyên môn khác đối với bất kỳ câu hỏi nào bạn có về tình trạng bệnh hoặc thuốc.

Nguồn dữ liệu: DailyMed (NLM), openFDA, MFDS